My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Omkar Speciality Chemicals gains after winning patent
Dec 14,2016

The announcement was made at the fag end of the trading session yesterday, 13 December 2016.

Meanwhile, the BSE Sensex was down 38.28 points, or 0.14%, to 26,659.54.

On the BSE, so far 1.16 lakh shares were traded in the counter, compared with average daily volumes of 49,749 shares in the past one quarter. The stock had hit a high of Rs 173.20 and a low of Rs 167.20 so far during the day.

The stock hit a record high of Rs 249.10 on 13 January 2016. The stock hit a 52-week low of Rs 130.05 on 9 November 2016. The stock had outperformed the market over the past 30 days till 13 December 2016, rising 10.05% compared with the 0.45% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 0.67% as against Sensexs 5.90% decline.

The small-cap company has equity capital of Rs 20.58 crore. Face value per share is Rs 10.

Omkar Speciality Chemicals said it has obtained a patent related to the process for preparation of higher derivatives of β -KETOESTER granted by the Government of India. With this, the total number of patents till date granted to the company stands at 4.

β -KETOESTERS are one of the basic building blocks from which advance molecules can be synthesized. It is used in various therapies such as cardiovascular diseases, treatment of dyslipidemia (cholesterol), various application in anti-microbial/anti-fungal activity and in synthesis of certain photographic chemicals.

Meanwhile, the company said it has applied for more process patents n++ some of which are expected in over the next 12-18 months. The product range covered under the above patents are iodo-alkalibenzoic acids, hydroxy diiodobenzoic acids, benzeneseleninic anhydride, alkali metal lodides, terminal dihaloalkanes, benzisothiazols, halquinol product, coumarin product, bromo amino derivatives of phenylene and iodine derivatives of alkanes.

On a consolidated basis, net profit of Omkar Speciality Chemicals rose 28.30% to Rs 11.56 crore on 27.80% rise in net sales to Rs 129.40 crore in Q2 September 2016 over Q2 September 2015.

Omkar Speciality Chemicals is amongst the leading manufacturers of specialty chemicals and intermediates for chemical and allied industries.

Powered by Capital Market - Live News

South Indian Bank gains after board plans to consider rights issue
Dec 14,2016

The announcement was made during market hours today, 14 December 2016.

Meanwhile, the BSE Sensex was down 44.52 points, or 0.17%, to 26,653.30.

On the BSE, 6.29 lakh shares were traded in the counter so far as against average daily volume of 7.39 lakh shares in the past one quarter. The stock hit high of Rs 22.50 and low of Rs 21.80 so far during the day. The stock had hit a 52-week high of Rs 25.55 on 7 October 2016. The stock had hit a 52-week low of Rs 16.40 on 29 February 2016.

The stock had underperformed the market over the past one month till 13 December 2016, falling 6% compared with 0.45% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, falling 4.57% as against Sensexs 5.84% decline.

The mid-cap bank has equity capital of Rs 135.17 crore. Face value per share is Re 1.

South Indian Banks net profit rose 18.4% to Rs 110.52 crore on 4.6% growth in total income to Rs 1596.08 crore in Q2 September 2016 over Q2 September 2015.

South Indian Bank is a private sector bank in India.

Powered by Capital Market - Live News

Bajaj Electricals rises after entering into strategic alliance with UK-based firm
Dec 14,2016

The announcement was made after market hours yesterday, 13 December 2016.

Meanwhile, the BSE Sensex was down 45.30 points, or 0.17%, to 26,652.52.

On the BSE, so far 8,998 shares were traded in the counter, compared with average daily volumes of 33,061 shares in the past one quarter. The stock had hit a high of Rs 225 and a low of Rs 220 so far during the day.

The stock hit a 52-week high of Rs 280 on 10 August 2016. The stock hit a 52-week low of Rs 155.35 on 29 February 2016. The stock had underperformed the market over the past 30 days till 13 December 2016, sliding 2.16% compared with the 0.45% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 18.79% as against Sensexs 5.90% decline.

The small-cap company has equity capital of Rs 20.24 crore. Face value per share is Rs 2.

Bajaj Electricals has entered into a strategic alliance with UK-based firm Gooee to take the next step in its journey towards digitization and in creating innovative lighting products and solutions on IoT (Internet of Things) platform. Under this arrangement, Gooee will be the first full stack operating platform providing Bajaj Electricals a service driven framework to deliver IoT applications to their discerning customers. IoT refers to the connection of devices other than computers and smartphones to the internet.

Bajaj Electricals net profit dropped 10.8% to Rs 16.66 crore on 10.4% fall in net sales to Rs 991.56 crore in Q2 September 2016 over Q2 September 2015.

Bajaj Electricals has a diversified business viz - consumer products (appliances, fans, lighting), exports, luminaires and EPC (illumination, transmission towers and power distribution).

Powered by Capital Market - Live News

NTPC nudges higher after announcing fund raising plans
Dec 14,2016

The announcement was made after market hours yesterday, 13 December 2016.

Meanwhile, the BSE Sensex was down 63.99 points, or 0.24%, to 26,633.83.

On the BSE, 15,308 shares were traded in the counter so far, compared with average daily volume of 3.02 lakh shares in the past one quarter. The stock had hit a high of Rs 166.40 and a low of Rs 164.45 so far during the day. The stock had hit a 52-week high of Rs 169.95 on 19 August 2016. The stock had hit a 52-week low of Rs 116.80 on 25 February 2016.

The stock had outperformed the market over the past 30 days till 13 December 2016, rising 8.45% compared with 0.45% decline in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 7.71% as against Sensexs 5.84% decline.

The large-cap company has equity capital of Rs 8245.46 crore. Face value per share is Rs 10.

NTPC announced that it has decided to raise Rs 3925 crore through private placement of secured non-convertible debentures at a coupon of 7.37% per annum with a door to door maturity of 15 years today, 14 December 2016.

The proceeds will be utilized to finance capital expenditure/refinancing the debt requirement in on-going projects and other general corporate requirements.

NTPCs net profit declined 17.9% to Rs 2495.97 crore on 8.4% rise in net sales to Rs 19241.47 crore in Q2 September 2016 over Q2 September 2015.

NTPC, Indias largest power company, has presence in the entire value chain of power generation business. The government of India holds 69.75% stake in the company as per the shareholding pattern as at 30 September 2016.

Powered by Capital Market - Live News

Wockhardt gains as Daman plant gets GMP certificate from UK MHRA
Dec 14,2016

The announcement was made after market hours yesterday, 13 December 2016.

Meanwhile, the BSE Sensex was down 54.22 points, or 0.20%, to 26,643.60.

On the BSE, so far 1.18 lakh shares were traded in the counter, compared with average daily volumes of 2.85 lakh shares in the past one quarter. The stock had hit a high of Rs 719 and a low of Rs 705.10 so far during the day.

The stock hit a 52-week high of Rs 1,654 on 18 December 2015. The stock hit a 52-week low of Rs 659 on 23 November 2016. The stock had underperformed the market over the past 30 days till 13 December 2016, falling 11.91% compared with the 0.45% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 17.05% as against Sensexs 5.90% decline.

The mid-cap company has equity capital of Rs 55.27 crore. Face value per share is Rs 5.

Wockhardt announced that UK MHRA (The Medicines and Healthcare products Regulatory Agency) has confirmed that the companys manufacturing unit at Kadaiya, Daman complies with the principles and guidelines of Good Manufacturing Practices. In view of this, the approval status of the unit continues.

Wockhardts consolidated net profit fell 81.59% to Rs 17.02 crore on 10.05% decline in total income to Rs 1084.59 crore in Q2 September 2016 over Q2 September 2015.

Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.

Powered by Capital Market - Live News

Amtek Auto slides after reporting dismal Q2 numbers
Dec 14,2016

The result was announced after market hours yesterday, 13 December 2016.

Meanwhile, the BSE Sensex was down 44.52 points, or 0.17%, to 26,653.30.

On the BSE, 1.27 lakh shares were traded in the counter so far, compared with average daily volume of 5.89 lakh shares in the past one quarter. The stock had hit a high of Rs 36.70 and a low of Rs 35.50 so far during the day. The stock had hit a 52-week high of Rs 56.20 on 26 July 2016. The stock had hit a 52-week low of Rs 26.05 on 12 February 2016.

The stock had outperformed the market over the past 30 days till 13 December 2016, falling 0.26% compared with 0.45% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 14.63% as against Sensexs 5.84% decline.

The small-cap company has equity capital of Rs 44.95 crore. Face value per share is Rs 2.

Amtek Autos total income fell 40.16% to Rs 498.92 crore in Q2 September 2016 over Q2 September 2015.

Amtek Auto is one of the largest integrated component manufacturers in India with a strong global presence. It has also become one of the worlds largest global forging and integrated machining companies.

Powered by Capital Market - Live News

Coal India declines after reporting weak Q2 results
Dec 14,2016

The result was announced after market hours yesterday, 13 December 2016.

Meanwhile, the S&P BSE Sensex was down 29 points or 0.11% at 26,668.31.

On the BSE, 71,351 shares were traded on the counter so far as against the average daily volumes of 3.37 lakh shares in the past one quarter. The stock had hit a high of Rs 298 and a low of Rs 295.25 so far during the day.

The large-cap company has equity capital of Rs 6316.36 crore. Face value per share is Rs 10.

State-run Coal India is Indias biggest coal miner. The Government of India currently holds 79.65% stake in Coal India (as per the shareholding pattern as on 30 September 2016).

Powered by Capital Market - Live News

Vascon Engineers gains ground on turnaround Q2 results
Dec 13,2016

The result was announced during market hours today, 13 December 2016.

More than usual volumes were witnessed on the counter. On the BSE, 3.91 lakh shares were traded in the counter so far, compared with an average volume of 2.52 lakh shares in the past one quarter. The stock had hit a high of Rs 33 and a low of Rs 30.90 so far during the day. The stock had hit a 52-week high of Rs 41.85 on 26 October 2016. The stock had hit a 52-week low of Rs 20.80 on 29 February 2016.

The stock had underperformed the market over the past one month till 12 December 2016, falling 2.35% compared with the 1.13% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 11.76% as against Sensexs 6.48% decline.

The small-cap company has an equity capital of Rs 161.34 crore. Face value per share is Rs 10.

Vascon Engineers net total income from operations fell 30.43% to Rs 52.92 crore in Q2 September 2016 over Q2 September 2015.

Separately, Vascon Engineers announced that the board of directors of the company at a meeting held today, 13 December 2016, approved the sale of its holding in Viorica Hotels for a consideration of Rs 15.60 crore.

Vascon Engineers is a premier realty, engineering, procurement & construction (EPC) & clean room partitioning companies.

Powered by Capital Market - Live News

Hindustan Copper slips after weak Q2 results
Dec 13,2016

The result was announced during trading hours today, 13 December 2016.

Meanwhile, the BSE Sensex was up 149.25 points, or 0.56%, to 26,664.49.

On the BSE, so far 3.02 lakh shares were traded in the counter, compared with average daily volumes of 1.69 lakh shares in the past one quarter. The stock had hit a high of Rs 64.60 and a low of Rs 60.90 so far during the day.

The stock hit a 52-week high of Rs 73.60 on 22 August 2016. The stock hit a 52-week low of Rs 42.30 on 19 February 2016. The stock had outperformed the market over the past 30 days till 12 December 2016, rising 5.25% compared with the 1.13% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 2.32% as against Sensexs 6.48% decline.

The mid-cap company has equity capital of Rs 462.61 crore. Face value per share is Rs 5.

Hindustan Copper (HCL), a public sector enterprise of the Government of India, has the distinction of being Indias only vertically integrated copper producing company encompassing mining, beneficiation, smelting, refining and casting of refined copper metal.

Powered by Capital Market - Live News

Swan Energy spurts after subsidiary receives maritime boards approval for LNG terminal
Dec 13,2016

The announcement was made during market hours today, 13 December 2016.

Huge volumes were witnessed on the counter. On the BSE, 17.33 lakh shares were traded in the counter so far as against average daily volume of 3.35 lakh shares in the past one quarter. The stock was locked at a high of Rs 201.35 in intraday trade. The stock hit a low of Rs 169.85 so far during the day.

The stock had outperformed the market over the past one month till 12 December 2016, jumping 25.13% compared with the 1.13% decline in the Sensex. The scrip had also outperformed the market in past one quarter, jumping 167.2% as against Sensexs 6.48% decline.

The small-cap company has an equity capital of Rs 22.12 crore. Face value per share is Re 1.

Swan Energy announced that through its 100% subsidiary company, Swan LNG (SLPL), has received approval from Gujarat Maritime Board (GMB) for commencement of construction of liquified natural gas (LNG) terminal with ancillary structures for its floating storage and re-gasification unit (FSRU) project at Jafrabad, Gujarat.

SLPL has executed an engineering, procurement and construction (EPC) contract for marine and dredging works worth Rs 2115 crore with National Marine & Infrastructure India (NMIIPL) for carrying out the construction of LNG terminal at Jafrabad, Gujarat, to be completed within 3 years. NMIIPL has already started the construction works.

Swan Energys net profit jumped 1170.6% to Rs 2.16 crore on 1.6% growth in net sales to Rs 96.09 crore in Q2 September 2016 over Q2 September 2015.

Swan Energy is an emerging green energy company with a pipeline of innovatively structured power projects.

Powered by Capital Market - Live News

Intellect Design Arena leads gainers in A group
Dec 13,2016

Intellect Design Arena surged 4.58% to Rs 172.45 at 13:45 IST. The stock topped the gainers in the BSEs A group. On the BSE, 5.28 lakh shares were traded on the counter so far as against the average daily volumes of 2.61 lakh shares in the past two weeks.

South Indian Bank jumped 3.71% at Rs 22.35. The stock was second biggest gainer in A group. On the BSE, 5.62 lakh shares were traded on the counter so far as against the average daily volumes of 4.81 lakh shares in the past two weeks.

Kotak Mahindra Bank gained 3.4% to Rs 110.90. The stock was the third biggest gainer in A group. On the BSE, 2.09 lakh shares were traded on the counter so far as against the average daily volumes of 3.89 lakh shares in the past two weeks.

Fortis Healthcare gained 3.11% at Rs 175.50. The stock was the fourth biggest gainer in A group. On the BSE, 75,000 shares were traded on the counter so far as against the average daily volumes of 78,000 shares in the past two weeks.

NCC rose 2.87% to Rs 84.10. The stock was the fifth biggest gainer in A group. On the BSE, 10.37 lakh shares were traded on the counter so far as against the average daily volumes of 4.63 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Artson Engineering jumps after receiving contract
Dec 13,2016

The announcement was made during market hours today, 13 December 2016.

Meanwhile, the BSE Sensex was up 86.19 points, or 0.33%, to 26,601.43.

More than usual volumes were witnessed on the counter. On the BSE, 55,599 shares were traded in the counter so far as against an average daily volume of 13,661 shares in the past one quarter. The stock hit high of Rs 51 and low of Rs 44.75 so far during the day. The stock had hit a 52-week high of Rs 64.90 on 23 December 2015. The stock had hit a 52-week low of Rs 34 on 1 March 2016.

The stock had underperformed the market over the past one month till 12 December 2016, falling 16.09% compared with the 1.13% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 19.87% as against Sensexs 6.48% decline.

The small-cap company has an equity capital of Rs 3.69 crore. Face value per share is Re 1.

Artson Engineering said that the contract is for design, detailed engineering, supply, fabrication, installation, testing, foundation work, fire protection, other civil works for double deck floating roof type crude oil storage tanks in Odisha, India.

Artson Engineering reported net profit of Rs 0.49 crore in Q2 September 2016, as compared with net loss of Rs 0.07 crore in Q2 September 2015. Net sales rose 1.3% to Rs 26.02 crore in Q2 September 2016 over Q2 September 2015.

Artson Engineering is a project engineering company. It offers multi-disciplinary design and construction services in the mechanical, civil, electrical and instrumentation fields. It offers turnkey services in petroleum storage and handling systems, plant utilities, diesel power houses, CPP, energy conservation, waste-heat recovery and noise pollution control systems.

Powered by Capital Market - Live News

Sun Pharma advances after signing exclusive global licensing deal with Moebius Medical
Dec 13,2016

The announcement was made after market hours yesterday, 12 December 2016.

Meanwhile, the BSE Sensex was up 70.19 points, or 0.26%, to 26,585.43.

On the BSE, 1.5 lakh shares were traded in the counter so far as against average daily volume of 4.7 lakh shares in the past one quarter. The stock had hit a high of Rs 682.50 and low of Rs 666.60, so far during the day. The stock had hit a 52-week high of Rs 898 on 23 February 2016. The stock had hit a 52-week low of Rs 572.40 on 9 November 2016.

The stock had underperformed the market over the past one month till 12 December 2016, falling 1.84% compared with the 1.13% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 14.06% as against Sensexs 6.48% decline.

The large-cap company has equity capital of Rs 240.68 crore. Face value per share is Rs 1.

Sun Pharmaceutical Industries and Israel-based Moebius Medical, a biotechnology company that is developing novel pain relief treatments for osteoarthritis have entered into an exclusive worldwide licensing deal to further develop MM-II, a novel pharmaceutical candidate for the treatment of pain in osteoarthritis.

MM-II is a novel non-opioid product that leverages the physical properties of proprietary liposomes to lubricate arthritic knee joints, thereby reducing friction and wear, consequently leading to joint pain reduction.

MM-II is an intra-articular biolubricant injection which is being developed to provide symptomatic relief of mild-to-moderate osteoarthritis pain. The product is based on patent-protected technology licensed by Moebius Medical from the Hebrew University of Jerusalem, Technion Israel Institute of Technology and Hadassah Medical Centre.

According to the agreement, Sun Pharma will fund further development of Moebius Medicals lead product, MM-II, and undertake its global commercialization. To date, Moebius Medical has completed a first-in-man clinical study at Hadassah Medical Center, demonstrating the products fast onset of action and its potentially better efficacy and comparable safety for alleviating osteoarthritis pain as compared to Hyaluronic Acid injection.

Moebius Medical will conduct requisite pre-clinical studies and will assume responsibility for product development and manufacturing through the end of phase-II studies. Sun Pharma will assume responsibility for further clinical studies, regulatory submissions and product commercialization. Moebius Medical will receive an upfront payment, development-based and sales-based milestone payments, and tiered royalties on sales from Sun Pharma.

On a consolidated basis, Sun Pharmaceutical Industries net profit surged 117.3% to Rs 2235.14 crore on 13.2% growth in net sales to Rs 7764.03 crore in Q2 September 2016 over Q2 September 2015.

Sun Pharmaceutical Industries is the worlds fifth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Syngene International tumbles after fire incident
Dec 13,2016

The announcement was made during trading hours today, 13 December 2016.

Meanwhile, the BSE Sensex was up 64.67 points, or 0.24%, to 26,579.91.

On the BSE, so far 49,000 shares were traded in the counter, compared with average daily volumes of 93,457 shares in the past one quarter. The stock had hit a high of Rs 625 and a low of Rs 594 so far during the day.

The stock hit a record high of Rs 663.30 on 9 December 2016. The stock hit a 52-week low of Rs 349 on 5 April 2016. The stock had outperformed the market over the past 30 days till 12 December 2016, rising 10.92% compared with the 1.13% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 34.11% as against Sensexs 6.48% decline.

The large-cap company has equity capital of Rs 200 crore. Face value per share is Rs 10.

There was a fire last night within one of the laboratory building (Building-S2) at Syngene International, which has since been bought under control. There has been no loss of life or any injury reported.

The S2 facility comprises laboratory and office space, representing representing approximately 10% of the total developed laboratory and office space on the campus.

The company is in the process of assessing the extent of damage to the building and equipment and also implementing its business continuity plan to minimize impact on operations.

The companys Industrial All Risk policy will help minimize the financial impact on account of damage to assets and loss of profits. Other facilities are not impacted and continue to operate as normal.

Net profit of Syngene International rose 54.02% to Rs 74.70 crore on 15.1% rise in net sales to Rs 294.70 crore in Q2 September 2016 over Q2 September 2015.

Promoted by Biocon, Syngene International is one of Asias largest contract research organizations. It provides discovery and developmental services for new molecular entities across multiple platforms including small molecules, large molecules, antibody-drug conjugates and oligonucleotides.

Powered by Capital Market - Live News

APL Apollo gains after receiving patents for four hollow section designs
Dec 13,2016

The announcement was made after market hours yesterday, 12 December 2016.

Meanwhile, the BSE Sensex was up 53.46 points, or 0.2%, to 26,568.70.

On the BSE, 1,052 shares were traded in the counter so far, compared with an average volume of 2,499 shares in the past one quarter. The stock had hit a high of Rs 885.75 and low of Rs 873 so far during the day. The stock hit a record high of Rs 1,008 on 18 August 2016. The stock hit a 52-week low of Rs 557 on 26 February 2016.

The stock had underperformed the market over the past one month till 12 December 2016, falling 5.8% compared with the 1.13% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 6.88% as against Sensexs 6.48% decline.

The small-cap company has an equity capital of Rs 23.59 crore. Face value per share is Rs 10.

APL Apollo Tubes announced that it received patents from the Indian Patent Office for four new designs of hollow section pipes. The patents cover the shapes and configurations of differentiated structural products.

The designs will have a patent for a period of 10 years, with a facility to further extend it for an additional period of 5 years. In addition to the four patents, APL Apollo holds another two design patents that it has developed in-house.

APL Apollo Tubes consolidated net profit rose 67.7% to Rs 33.66 crore on 12.9% decline in net sales to Rs 927.99 crore in Q2 September 2016 over Q2 September 2015.

APL Apollo Tubes is one of the leading manufacturers of hollow section steel tubes and pre-galvanized steel tubes in the country.

Powered by Capital Market - Live News